United States· US:45802-717_5def32af-7e22-4dbf-b0cd-aca45e2987b0

Terconazole

A terconazole product containing terconazole, registered in United States by Padagis Israel Pharmaceuticals Ltd. The same ATC class is registered in 3 of our 19 countries.

ATC G01AG02US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedTerconazoleATCG01AG02REGISTER NO.US:45802-717_5def32af…PACKS LISTED2CHECKEDAugust 9, 2026

Where it is registered

Terconazole is registered in 3 of 19 countries.

Countries holding a registration under ATC G01AG02 (terconazole), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 2 of them publish a price we can compare per daily dose

Terconazole · ATC G01AG02

3 / 19 countries

  • Canada
  • Finlandprice
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of terconazole costs, country by country.

Normalised to the WHO defined daily dose (80 mg), so markets compare like for like.

  • United States: $18.62 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown

Terconazole · price per daily dose (80 mg)

USD · FX 28 Sept 2026

  • US United States$18.62 (acquisition cost)
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
TERCONAZOLE
Manufacturer
Padagis Israel Pharmaceuticals Ltd
Country
United States (US)
ATC code
G01AG02
ATC class
Terconazole
Defined daily dose
80 mg, V
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
August 9, 2026

Packs & prices · 2

  • ndc11
    45802-717-08
  • ndc11
    4580271708
    3 BLISTER PACK in 1 CARTON (45802-717-08) / 1 SUPPOSITORY in 1 BLISTER PACK (45802-717-00)

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Terconazole in 1 other country

What each register calls a product with the same active substance — salts and hydrates count as the same.

All terconazole products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ddad1e75-d9c9-4a76-9d03-a13133edf6c5
GET /v1/drugs/ddad1e75-d9c9-4a76-9d03-a13133edf6c5?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "VAGINAL",
  "source": "ndc",
  "strength": "80",
  "substance": "TERCONAZOLE",
  "productndc": "45802-717",
  "dosage_form": "SUPPOSITORY",
  "dea_schedule": null,
  "strength_unit": "mg/1",
  "application_number": "ANDA077149",
  "marketing_category": "ANDA"
}

See everything about terconazole.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.